Dilafor raises SEK 51 million to facilitate Phase IIb clinical study with Tafoxiparin 2016.09.27

 
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD